MBOT Valuation

Microbot Medical Inc

Add to Watchlist

Advanced Chart

2.450

-0.02(-0.810%)1D

Overview
Forecast
Valuation
Earnings

MBOT Relative Valuation

MBOT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MBOT is overvalued; if below, it's undervalued.

Historical Valuation

Microbot Medical Inc (MBOT) is now in the Fair zone, suggesting that its current forward PS ratio of 15.90 is considered Fairly compared with the five-year average of -3.44. The fair price of Microbot Medical Inc (MBOT) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：2.51

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.96

P/B

Median3y

3.81

Median5y

3.31

-9.95

FCF Yield

Median3y

-44.79

Median5y

-33.82

Competitors Valuation Multiple

The average P/S ratio for MBOT's competitors is 71.79, providing a benchmark for relative valuation. Microbot Medical Inc Corp (MBOT) exhibits a P/S ratio of 15.59, which is -78.29% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap